nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—Lisdexamfetamine—Lisinopril—systemic scleroderma	0.297	0.365	CrCrCtD
Dextroamphetamine—Nateglinide—Lisinopril—systemic scleroderma	0.265	0.326	CrCrCtD
Dextroamphetamine—Aspartame—Lisinopril—systemic scleroderma	0.251	0.309	CrCrCtD
Dextroamphetamine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000512	0.00274	CcSEcCtD
Dextroamphetamine—Tremor—Mycophenolic acid—systemic scleroderma	0.000512	0.00274	CcSEcCtD
Dextroamphetamine—Body temperature increased—Mometasone—systemic scleroderma	0.000511	0.00273	CcSEcCtD
Dextroamphetamine—Abdominal pain—Mometasone—systemic scleroderma	0.000511	0.00273	CcSEcCtD
Dextroamphetamine—Palpitations—Leflunomide—systemic scleroderma	0.000507	0.00271	CcSEcCtD
Dextroamphetamine—Dyspnoea—Captopril—systemic scleroderma	0.000506	0.00271	CcSEcCtD
Dextroamphetamine—Somnolence—Captopril—systemic scleroderma	0.000505	0.0027	CcSEcCtD
Dextroamphetamine—Agitation—Mycophenolic acid—systemic scleroderma	0.000502	0.00269	CcSEcCtD
Dextroamphetamine—Dyspepsia—Captopril—systemic scleroderma	0.0005	0.00267	CcSEcCtD
Dextroamphetamine—Dizziness—Pentoxifylline—systemic scleroderma	0.000495	0.00265	CcSEcCtD
Dextroamphetamine—Hypertension—Leflunomide—systemic scleroderma	0.000495	0.00265	CcSEcCtD
Dextroamphetamine—Decreased appetite—Captopril—systemic scleroderma	0.000493	0.00264	CcSEcCtD
Dextroamphetamine—Infection—Azathioprine—systemic scleroderma	0.000492	0.00263	CcSEcCtD
Dextroamphetamine—Fatigue—Captopril—systemic scleroderma	0.000489	0.00262	CcSEcCtD
Dextroamphetamine—Chest pain—Leflunomide—systemic scleroderma	0.000488	0.00261	CcSEcCtD
Dextroamphetamine—Anxiety—Leflunomide—systemic scleroderma	0.000486	0.0026	CcSEcCtD
Dextroamphetamine—Constipation—Captopril—systemic scleroderma	0.000485	0.0026	CcSEcCtD
Dextroamphetamine—Tension—Lisinopril—systemic scleroderma	0.000483	0.00258	CcSEcCtD
Dextroamphetamine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000483	0.00258	CcSEcCtD
Dextroamphetamine—Nervousness—Lisinopril—systemic scleroderma	0.000478	0.00256	CcSEcCtD
Dextroamphetamine—Affect lability—Prednisone—systemic scleroderma	0.000478	0.00256	CcSEcCtD
Dextroamphetamine—Dry mouth—Leflunomide—systemic scleroderma	0.000477	0.00255	CcSEcCtD
Dextroamphetamine—Vomiting—Pentoxifylline—systemic scleroderma	0.000476	0.00255	CcSEcCtD
Dextroamphetamine—Psychotic disorder—Prednisone—systemic scleroderma	0.000474	0.00254	CcSEcCtD
Dextroamphetamine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000474	0.00253	CcSEcCtD
Dextroamphetamine—Rash—Pentoxifylline—systemic scleroderma	0.000472	0.00252	CcSEcCtD
Dextroamphetamine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000472	0.00252	CcSEcCtD
Dextroamphetamine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000472	0.00252	CcSEcCtD
Dextroamphetamine—Headache—Pentoxifylline—systemic scleroderma	0.000469	0.00251	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000468	0.0025	CcSEcCtD
Dextroamphetamine—Chest pain—Mycophenolic acid—systemic scleroderma	0.000466	0.00249	CcSEcCtD
Dextroamphetamine—Infection—Leflunomide—systemic scleroderma	0.000465	0.00248	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000464	0.00248	CcSEcCtD
Dextroamphetamine—Anxiety—Mycophenolic acid—systemic scleroderma	0.000464	0.00248	CcSEcCtD
Dextroamphetamine—Asthenia—Mometasone—systemic scleroderma	0.000464	0.00248	CcSEcCtD
Dextroamphetamine—Irritability—Prednisone—systemic scleroderma	0.000464	0.00248	CcSEcCtD
Dextroamphetamine—Tremor—Lisinopril—systemic scleroderma	0.000461	0.00247	CcSEcCtD
Dextroamphetamine—Mood swings—Prednisone—systemic scleroderma	0.00046	0.00246	CcSEcCtD
Dextroamphetamine—Tachycardia—Leflunomide—systemic scleroderma	0.000457	0.00244	CcSEcCtD
Dextroamphetamine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000455	0.00243	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000452	0.00242	CcSEcCtD
Dextroamphetamine—Angioedema—Lisinopril—systemic scleroderma	0.00045	0.00241	CcSEcCtD
Dextroamphetamine—Body temperature increased—Captopril—systemic scleroderma	0.000449	0.0024	CcSEcCtD
Dextroamphetamine—Abdominal pain—Captopril—systemic scleroderma	0.000449	0.0024	CcSEcCtD
Dextroamphetamine—Anorexia—Leflunomide—systemic scleroderma	0.000446	0.00238	CcSEcCtD
Dextroamphetamine—Nausea—Pentoxifylline—systemic scleroderma	0.000445	0.00238	CcSEcCtD
Dextroamphetamine—Infection—Mycophenolic acid—systemic scleroderma	0.000443	0.00237	CcSEcCtD
Dextroamphetamine—Diarrhoea—Mometasone—systemic scleroderma	0.000442	0.00236	CcSEcCtD
Dextroamphetamine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000436	0.00233	CcSEcCtD
Dextroamphetamine—Palpitations—Lisinopril—systemic scleroderma	0.000435	0.00233	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000431	0.00231	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000428	0.00229	CcSEcCtD
Dextroamphetamine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000425	0.00227	CcSEcCtD
Dextroamphetamine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000423	0.00226	CcSEcCtD
Dextroamphetamine—Insomnia—Leflunomide—systemic scleroderma	0.000423	0.00226	CcSEcCtD
Dextroamphetamine—Chest pain—Lisinopril—systemic scleroderma	0.000419	0.00224	CcSEcCtD
Dextroamphetamine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000419	0.00224	CcSEcCtD
Dextroamphetamine—Anxiety—Lisinopril—systemic scleroderma	0.000418	0.00223	CcSEcCtD
Dextroamphetamine—Dyspnoea—Leflunomide—systemic scleroderma	0.000417	0.00223	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000414	0.00221	CcSEcCtD
Dextroamphetamine—Dyspepsia—Leflunomide—systemic scleroderma	0.000412	0.0022	CcSEcCtD
Dextroamphetamine—Vomiting—Mometasone—systemic scleroderma	0.000411	0.0022	CcSEcCtD
Dextroamphetamine—Dry mouth—Lisinopril—systemic scleroderma	0.00041	0.00219	CcSEcCtD
Dextroamphetamine—Rash—Mometasone—systemic scleroderma	0.000407	0.00218	CcSEcCtD
Dextroamphetamine—Asthenia—Captopril—systemic scleroderma	0.000407	0.00218	CcSEcCtD
Dextroamphetamine—Dermatitis—Mometasone—systemic scleroderma	0.000407	0.00218	CcSEcCtD
Dextroamphetamine—Decreased appetite—Leflunomide—systemic scleroderma	0.000407	0.00217	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000405	0.00217	CcSEcCtD
Dextroamphetamine—Headache—Mometasone—systemic scleroderma	0.000405	0.00216	CcSEcCtD
Dextroamphetamine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000404	0.00216	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000404	0.00216	CcSEcCtD
Dextroamphetamine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000404	0.00216	CcSEcCtD
Dextroamphetamine—Fatigue—Leflunomide—systemic scleroderma	0.000403	0.00216	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000402	0.00215	CcSEcCtD
Dextroamphetamine—Constipation—Leflunomide—systemic scleroderma	0.0004	0.00214	CcSEcCtD
Dextroamphetamine—Infection—Lisinopril—systemic scleroderma	0.000399	0.00214	CcSEcCtD
Dextroamphetamine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000398	0.00213	CcSEcCtD
Dextroamphetamine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000397	0.00212	CcSEcCtD
Dextroamphetamine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000397	0.00212	CcSEcCtD
Dextroamphetamine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000394	0.00211	CcSEcCtD
Dextroamphetamine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000393	0.0021	CcSEcCtD
Dextroamphetamine—Tachycardia—Lisinopril—systemic scleroderma	0.000392	0.0021	CcSEcCtD
Dextroamphetamine—Abdominal pain—Azathioprine—systemic scleroderma	0.000392	0.00209	CcSEcCtD
Dextroamphetamine—Body temperature increased—Azathioprine—systemic scleroderma	0.000392	0.00209	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000389	0.00208	CcSEcCtD
Dextroamphetamine—Diarrhoea—Captopril—systemic scleroderma	0.000388	0.00208	CcSEcCtD
Dextroamphetamine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000388	0.00207	CcSEcCtD
Dextroamphetamine—Irritability—Methotrexate—systemic scleroderma	0.000387	0.00207	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000387	0.00207	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000385	0.00206	CcSEcCtD
Dextroamphetamine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000385	0.00206	CcSEcCtD
Dextroamphetamine—Mood swings—Methotrexate—systemic scleroderma	0.000385	0.00206	CcSEcCtD
Dextroamphetamine—Nausea—Mometasone—systemic scleroderma	0.000384	0.00205	CcSEcCtD
Dextroamphetamine—Anorexia—Lisinopril—systemic scleroderma	0.000383	0.00205	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000383	0.00205	CcSEcCtD
Dextroamphetamine—Constipation—Mycophenolic acid—systemic scleroderma	0.000382	0.00204	CcSEcCtD
Dextroamphetamine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000381	0.00204	CcSEcCtD
Dextroamphetamine—Weight decreased—Prednisone—systemic scleroderma	0.00038	0.00203	CcSEcCtD
Dextroamphetamine—Dizziness—Captopril—systemic scleroderma	0.000375	0.00201	CcSEcCtD
Dextroamphetamine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000374	0.002	CcSEcCtD
Dextroamphetamine—Depression—Prednisone—systemic scleroderma	0.000373	0.002	CcSEcCtD
Dextroamphetamine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000373	0.00199	CcSEcCtD
Dextroamphetamine—Urticaria—Leflunomide—systemic scleroderma	0.000372	0.00199	CcSEcCtD
Dextroamphetamine—Body temperature increased—Leflunomide—systemic scleroderma	0.00037	0.00198	CcSEcCtD
Dextroamphetamine—Abdominal pain—Leflunomide—systemic scleroderma	0.00037	0.00198	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000369	0.00197	CcSEcCtD
Dextroamphetamine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000367	0.00196	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Prednisone—systemic scleroderma	0.000367	0.00196	CcSEcCtD
Dextroamphetamine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000366	0.00196	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000366	0.00195	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000365	0.00195	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000365	0.00195	CcSEcCtD
Dextroamphetamine—Insomnia—Lisinopril—systemic scleroderma	0.000364	0.00194	CcSEcCtD
Dextroamphetamine—Vomiting—Captopril—systemic scleroderma	0.000361	0.00193	CcSEcCtD
Dextroamphetamine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000359	0.00192	CcSEcCtD
Dextroamphetamine—Dyspnoea—Lisinopril—systemic scleroderma	0.000358	0.00192	CcSEcCtD
Dextroamphetamine—Rash—Captopril—systemic scleroderma	0.000358	0.00191	CcSEcCtD
Dextroamphetamine—Dermatitis—Captopril—systemic scleroderma	0.000358	0.00191	CcSEcCtD
Dextroamphetamine—Somnolence—Lisinopril—systemic scleroderma	0.000357	0.00191	CcSEcCtD
Dextroamphetamine—Headache—Captopril—systemic scleroderma	0.000356	0.0019	CcSEcCtD
Dextroamphetamine—Dyspepsia—Lisinopril—systemic scleroderma	0.000354	0.00189	CcSEcCtD
Dextroamphetamine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000353	0.00189	CcSEcCtD
Dextroamphetamine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000353	0.00189	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000352	0.00188	CcSEcCtD
Dextroamphetamine—Infection—Mycophenolate mofetil—systemic scleroderma	0.00035	0.00187	CcSEcCtD
Dextroamphetamine—Decreased appetite—Lisinopril—systemic scleroderma	0.000349	0.00187	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000347	0.00186	CcSEcCtD
Dextroamphetamine—Fatigue—Lisinopril—systemic scleroderma	0.000347	0.00185	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000345	0.00184	CcSEcCtD
Dextroamphetamine—Constipation—Lisinopril—systemic scleroderma	0.000344	0.00184	CcSEcCtD
Dextroamphetamine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000344	0.00184	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00034	0.00182	CcSEcCtD
Dextroamphetamine—Diarrhoea—Azathioprine—systemic scleroderma	0.000339	0.00181	CcSEcCtD
Dextroamphetamine—Nausea—Captopril—systemic scleroderma	0.000337	0.0018	CcSEcCtD
Dextroamphetamine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000336	0.00179	CcSEcCtD
Dextroamphetamine—Asthenia—Leflunomide—systemic scleroderma	0.000336	0.00179	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000329	0.00176	CcSEcCtD
Dextroamphetamine—Dizziness—Azathioprine—systemic scleroderma	0.000328	0.00175	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000323	0.00173	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00032	0.00171	CcSEcCtD
Dextroamphetamine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00032	0.00171	CcSEcCtD
Dextroamphetamine—Diarrhoea—Leflunomide—systemic scleroderma	0.00032	0.00171	CcSEcCtD
Dextroamphetamine—Urticaria—Lisinopril—systemic scleroderma	0.000319	0.00171	CcSEcCtD
Dextroamphetamine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000319	0.0017	CcSEcCtD
Dextroamphetamine—Abdominal pain—Lisinopril—systemic scleroderma	0.000318	0.0017	CcSEcCtD
Dextroamphetamine—Body temperature increased—Lisinopril—systemic scleroderma	0.000318	0.0017	CcSEcCtD
Dextroamphetamine—Vomiting—Azathioprine—systemic scleroderma	0.000315	0.00168	CcSEcCtD
Dextroamphetamine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000314	0.00168	CcSEcCtD
Dextroamphetamine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000313	0.00167	CcSEcCtD
Dextroamphetamine—Rash—Azathioprine—systemic scleroderma	0.000312	0.00167	CcSEcCtD
Dextroamphetamine—Dermatitis—Azathioprine—systemic scleroderma	0.000312	0.00167	CcSEcCtD
Dextroamphetamine—Depression—Methotrexate—systemic scleroderma	0.000312	0.00167	CcSEcCtD
Dextroamphetamine—Headache—Azathioprine—systemic scleroderma	0.00031	0.00166	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00031	0.00166	CcSEcCtD
Dextroamphetamine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00031	0.00166	CcSEcCtD
Dextroamphetamine—Dizziness—Leflunomide—systemic scleroderma	0.000309	0.00165	CcSEcCtD
Dextroamphetamine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000306	0.00164	CcSEcCtD
Dextroamphetamine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000305	0.00163	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000304	0.00163	CcSEcCtD
Dextroamphetamine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000301	0.00161	CcSEcCtD
Dextroamphetamine—Sweating—Methotrexate—systemic scleroderma	0.0003	0.0016	CcSEcCtD
Dextroamphetamine—Vomiting—Leflunomide—systemic scleroderma	0.000297	0.00159	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000296	0.00158	CcSEcCtD
Dextroamphetamine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000295	0.00158	CcSEcCtD
Dextroamphetamine—Rash—Leflunomide—systemic scleroderma	0.000295	0.00158	CcSEcCtD
Dextroamphetamine—Dermatitis—Leflunomide—systemic scleroderma	0.000295	0.00158	CcSEcCtD
Dextroamphetamine—Nausea—Azathioprine—systemic scleroderma	0.000294	0.00157	CcSEcCtD
Dextroamphetamine—Headache—Leflunomide—systemic scleroderma	0.000293	0.00157	CcSEcCtD
Dextroamphetamine—Asthenia—Lisinopril—systemic scleroderma	0.000288	0.00154	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000288	0.00154	CcSEcCtD
Dextroamphetamine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000284	0.00152	CcSEcCtD
Dextroamphetamine—Rash—Mycophenolic acid—systemic scleroderma	0.000281	0.0015	CcSEcCtD
Dextroamphetamine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000281	0.0015	CcSEcCtD
Dextroamphetamine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00028	0.0015	CcSEcCtD
Dextroamphetamine—Headache—Mycophenolic acid—systemic scleroderma	0.00028	0.00149	CcSEcCtD
Dextroamphetamine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000278	0.00149	CcSEcCtD
Dextroamphetamine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000278	0.00149	CcSEcCtD
Dextroamphetamine—Nausea—Leflunomide—systemic scleroderma	0.000278	0.00149	CcSEcCtD
Dextroamphetamine—Diarrhoea—Lisinopril—systemic scleroderma	0.000275	0.00147	CcSEcCtD
Dextroamphetamine—Agitation—Prednisone—systemic scleroderma	0.000269	0.00144	CcSEcCtD
Dextroamphetamine—Angioedema—Prednisone—systemic scleroderma	0.000267	0.00143	CcSEcCtD
Dextroamphetamine—Dizziness—Lisinopril—systemic scleroderma	0.000266	0.00142	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000266	0.00142	CcSEcCtD
Dextroamphetamine—Nausea—Mycophenolic acid—systemic scleroderma	0.000265	0.00142	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000259	0.00139	CcSEcCtD
Dextroamphetamine—Vomiting—Lisinopril—systemic scleroderma	0.000256	0.00137	CcSEcCtD
Dextroamphetamine—Rash—Lisinopril—systemic scleroderma	0.000253	0.00136	CcSEcCtD
Dextroamphetamine—Convulsion—Prednisone—systemic scleroderma	0.000253	0.00136	CcSEcCtD
Dextroamphetamine—Dermatitis—Lisinopril—systemic scleroderma	0.000253	0.00135	CcSEcCtD
Dextroamphetamine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00135	CcSEcCtD
Dextroamphetamine—Hypertension—Prednisone—systemic scleroderma	0.000253	0.00135	CcSEcCtD
Dextroamphetamine—Headache—Lisinopril—systemic scleroderma	0.000252	0.00135	CcSEcCtD
Dextroamphetamine—Anxiety—Prednisone—systemic scleroderma	0.000248	0.00133	CcSEcCtD
Dextroamphetamine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000241	0.00129	CcSEcCtD
Dextroamphetamine—Nausea—Lisinopril—systemic scleroderma	0.000239	0.00128	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000239	0.00128	CcSEcCtD
Dextroamphetamine—Infection—Prednisone—systemic scleroderma	0.000237	0.00127	CcSEcCtD
Dextroamphetamine—Tachycardia—Prednisone—systemic scleroderma	0.000233	0.00125	CcSEcCtD
Dextroamphetamine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000233	0.00125	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000231	0.00123	CcSEcCtD
Dextroamphetamine—Anorexia—Prednisone—systemic scleroderma	0.000228	0.00122	CcSEcCtD
Dextroamphetamine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000224	0.0012	CcSEcCtD
Dextroamphetamine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000222	0.00119	CcSEcCtD
Dextroamphetamine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000222	0.00119	CcSEcCtD
Dextroamphetamine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000221	0.00118	CcSEcCtD
Dextroamphetamine—Insomnia—Prednisone—systemic scleroderma	0.000216	0.00115	CcSEcCtD
Dextroamphetamine—Convulsion—Methotrexate—systemic scleroderma	0.000212	0.00113	CcSEcCtD
Dextroamphetamine—Dyspepsia—Prednisone—systemic scleroderma	0.00021	0.00112	CcSEcCtD
Dextroamphetamine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000209	0.00112	CcSEcCtD
Dextroamphetamine—Chest pain—Methotrexate—systemic scleroderma	0.000208	0.00111	CcSEcCtD
Dextroamphetamine—Decreased appetite—Prednisone—systemic scleroderma	0.000208	0.00111	CcSEcCtD
Dextroamphetamine—Fatigue—Prednisone—systemic scleroderma	0.000206	0.0011	CcSEcCtD
Dextroamphetamine—Constipation—Prednisone—systemic scleroderma	0.000204	0.00109	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.0002	0.00107	CcSEcCtD
Dextroamphetamine—Infection—Methotrexate—systemic scleroderma	0.000198	0.00106	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000195	0.00104	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000193	0.00103	CcSEcCtD
Dextroamphetamine—Anorexia—Methotrexate—systemic scleroderma	0.00019	0.00102	CcSEcCtD
Dextroamphetamine—Urticaria—Prednisone—systemic scleroderma	0.00019	0.00101	CcSEcCtD
Dextroamphetamine—Abdominal pain—Prednisone—systemic scleroderma	0.000189	0.00101	CcSEcCtD
Dextroamphetamine—Body temperature increased—Prednisone—systemic scleroderma	0.000189	0.00101	CcSEcCtD
Dextroamphetamine—Insomnia—Methotrexate—systemic scleroderma	0.00018	0.000965	CcSEcCtD
Dextroamphetamine—Dyspnoea—Methotrexate—systemic scleroderma	0.000178	0.000951	CcSEcCtD
Dextroamphetamine—Somnolence—Methotrexate—systemic scleroderma	0.000177	0.000948	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Prednisone—systemic scleroderma	0.000176	0.00094	CcSEcCtD
Dextroamphetamine—Dyspepsia—Methotrexate—systemic scleroderma	0.000176	0.000939	CcSEcCtD
Dextroamphetamine—Decreased appetite—Methotrexate—systemic scleroderma	0.000173	0.000927	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000172	0.000921	CcSEcCtD
Dextroamphetamine—Fatigue—Methotrexate—systemic scleroderma	0.000172	0.00092	CcSEcCtD
Dextroamphetamine—Asthenia—Prednisone—systemic scleroderma	0.000171	0.000916	CcSEcCtD
Dextroamphetamine—Diarrhoea—Prednisone—systemic scleroderma	0.000163	0.000873	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000163	0.000872	CcSEcCtD
Dextroamphetamine—Urticaria—Methotrexate—systemic scleroderma	0.000158	0.000847	CcSEcCtD
Dextroamphetamine—Dizziness—Prednisone—systemic scleroderma	0.000158	0.000844	CcSEcCtD
Dextroamphetamine—Abdominal pain—Methotrexate—systemic scleroderma	0.000158	0.000843	CcSEcCtD
Dextroamphetamine—Body temperature increased—Methotrexate—systemic scleroderma	0.000158	0.000843	CcSEcCtD
Dextroamphetamine—Vomiting—Prednisone—systemic scleroderma	0.000152	0.000812	CcSEcCtD
Dextroamphetamine—Rash—Prednisone—systemic scleroderma	0.000151	0.000805	CcSEcCtD
Dextroamphetamine—Dermatitis—Prednisone—systemic scleroderma	0.00015	0.000804	CcSEcCtD
Dextroamphetamine—Headache—Prednisone—systemic scleroderma	0.00015	0.0008	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000147	0.000786	CcSEcCtD
Dextroamphetamine—Asthenia—Methotrexate—systemic scleroderma	0.000143	0.000765	CcSEcCtD
Dextroamphetamine—Nausea—Prednisone—systemic scleroderma	0.000142	0.000758	CcSEcCtD
Dextroamphetamine—Diarrhoea—Methotrexate—systemic scleroderma	0.000137	0.00073	CcSEcCtD
Dextroamphetamine—Dizziness—Methotrexate—systemic scleroderma	0.000132	0.000705	CcSEcCtD
Dextroamphetamine—Vomiting—Methotrexate—systemic scleroderma	0.000127	0.000678	CcSEcCtD
Dextroamphetamine—Rash—Methotrexate—systemic scleroderma	0.000126	0.000673	CcSEcCtD
Dextroamphetamine—Dermatitis—Methotrexate—systemic scleroderma	0.000126	0.000672	CcSEcCtD
Dextroamphetamine—Headache—Methotrexate—systemic scleroderma	0.000125	0.000668	CcSEcCtD
Dextroamphetamine—Nausea—Methotrexate—systemic scleroderma	0.000119	0.000634	CcSEcCtD
